MENU
Showcases Stock ranks Forex

Kitov Pharma Ltd (KTOV)
  0 (0%) 04-25 07:41
Open: Pre. Close:
High: Low:
Volume: 0 Market Cap: 0(M)
Stock Technical Analysis
Overall:     
Target: Six months: 8.47
One year: 9.89
Support: Support1: 5.19
Support2: 3.91
Resistance: Resistance1: 7.25
Resistance2: 8.47
Pivot: 5.33
Moving Averages: MA(5): 5.89
MA(20): 5.10
MA(100): 4.40
MA(250): 4.95
MACD: MACD(12,26): 0.47
Signal(12,26,9): 0.40
%K %D: %K(14,3): 59.38
%D(3): 58.05
RSI: RSI(14): 60.18
52-Week: High:
Low:
Change(%): -14.1
Average Vol(K): 3-Month: 78894
10-Days: 239958
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 6.158 - 6.188 6.188 - 6.217
Low: 5.725 - 5.761 5.761 - 5.797
Close: 5.862 - 5.92 5.92 - 5.978
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

KTOV has closed below upper band by 34.8%. Bollinger Bands are 354.7% wider than normal. The large width of the bands suggest high volatility as compared to KTOV's normal range. The bands have been in this wide range for 21 bars. This is a sign that the current trend might continue.
Company profile
Stock chart
Stock News
Tue, 25 May 2021
Scopus BioPharma soars on FDA approval - Globes - Globes

Wed, 14 Oct 2020
Fresh U.S Stocks Under Consideration Kitov Pharmaceuticals Holdings (TLV:KTOV), Ctrip.com International, (NASDAQ ... - Stocks Newswire

Thu, 09 Jul 2020
Aeterna Zentaris Inc. (NASDAQ:AEZS) Enters Strategic Distribution Agreement For Marketing Of Macimorelin In Middle ... - BP Journal

Thu, 09 Jul 2020
Kitov Pharma Ltd (NASDAQ:KTOV) CONSENSI® Approved In The US For Osteoarthritis Pain And Hypertension - BP Journal

Fri, 05 Jun 2020
Penny Stocks To Watch In June 2020; 1 Up Over 120% - Penny Stocks

Wed, 08 Jan 2020
Kitov Pharma Announces Closing of FameWave Acquisition - GlobeNewswire

Financial Analysis
Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange: 
Sector: 
Industry: 
Shares Out. (M) 17.21
Shares Float (M) 15.45
% Held by Insiders 1.91
% Held by Institutions 14.58
Shares Short (K) 44
Shares Short Prior Month (K) 184
Stock Financials
EPS -7.800
Book Value (p.s.) 3.540
Profit Margin
Operating Margin -753.90
Return on Assets (ttm) -9.1
Return on Equity (ttm) -92.0
Qtrly Rev. Growth
Gross Profit (p.s.) 0.058
Sales Per Share 0.058
EBITDA (p.s.) -0.438
Qtrly Earnings Growth
Operating Cash Flow (M) -7.95
Levered Free Cash Flow (M) 21.78
Stock Valuation
PE Ratio -0.76
PEG Ratio
Price to Book value 1.68
Price to Sales 102.06
Price to Cash Flow -12.84
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android